Literature DB >> 10627357

Practice and potential pitfalls of coronary pressure measurement.

N H Pijls1, M J Kern, P G Yock, B De Bruyne.   

Abstract

Guidewire-based coronary pressure measurement has emerged over the last years as a promising approach in the invasive assessment of coronary artery disease. It enables calculation of fractional flow reserve (FFR) which closely relates distal coronary pressure to myocardial blood flow during maximal arteriolar vasodilation. Coronary pressure measurement and FFR provide important information, both for decision making in diagnostic angiography and for monitoring and evaluating coronary interventions. In this review, the practical set-up of coronary pressure measurement in the catheterization laboratory is discussed step-by-step, special attention is given to potential pitfalls and how to avoid them, and the interpretation of coronary pressure measurement in a variety of pathologic conditions is clarified. Cathet. Cardiovasc. Intervent. 49:1-16, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10627357     DOI: 10.1002/(sici)1522-726x(200001)49:1<1::aid-ccd1>3.0.co;2-5

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  30 in total

1.  Use of a pressure-sensing wire to detect sequential pressure gradients for ipsilateral vertebral and subclavian artery stenoses.

Authors:  Chung-Pin Liu; Yen-Hung Ling; Hsien-Li Kao
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

Review 2.  Combined functional and anatomical diagnostic endpoints for assessing arteriovenous fistula dysfunction.

Authors:  Ehsan Rajabi-Jaghargh; Rupak K Banerjee
Journal:  World J Nephrol       Date:  2015-02-06

Review 3.  Myocardial fractional flow reserve. Its role in guiding PCI in stable coronary artery disease.

Authors:  M Lindstaedt; A Mügge
Journal:  Herz       Date:  2011-08       Impact factor: 1.443

Review 4.  Clinical Application of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention for Stable Coronary Artery Disease.

Authors:  Valay Parikh; Kanishk Agnihotri; Sabeeda Kadavath; Nileshkumar J Patel; J Dawn Abbott
Journal:  Curr Cardiol Rep       Date:  2016-04       Impact factor: 2.931

5.  Residual angina pectoris after percutaneous coronary intervention for acute coronary syndrome.

Authors:  M Michels; H Werner; E Onderwater; W J van der Giessen
Journal:  Neth Heart J       Date:  2005-09       Impact factor: 2.380

6.  Clinical outcomes of combined flow-pressure drop measurements using newly developed diagnostic endpoint: Pressure drop coefficient in patients with coronary artery dysfunction.

Authors:  Mohamed A Effat; Srikara Viswanath Peelukhana; Rupak K Banerjee
Journal:  World J Cardiol       Date:  2016-03-26

7.  Major influence of a 'smoke and mirrors' effect caused by wave reflection on early diastolic coronary arterial wave intensity.

Authors:  Jonathan P Mynard; Daniel J Penny; Joseph J Smolich
Journal:  J Physiol       Date:  2018-02-13       Impact factor: 5.182

8.  Performing and Interpreting Fractional Flow Reserve Measurements in Clinical Practice: An Expert Consensus Document.

Authors:  Stephan Achenbach; Tanja Rudolph; Johannes Rieber; Holger Eggebrecht; Gert Richardt; Thomas Schmitz; Nikos Werner; Florian Boenner; Helge Möllmann
Journal:  Interv Cardiol       Date:  2017-09

9.  Recovery of impaired microvascular function in collateral dependent myocardium after recanalisation of a chronic total coronary occlusion.

Authors:  G S Werner; U Emig; P Bahrmann; M Ferrari; H R Figulla
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

10.  Adenosine-induced maximal coronary hyperemia for myocardial fractional flow reserve measurements: comparison of administration by femoral venous versus antecubital venous access.

Authors:  Michael Lindstaedt; Waldemar Bojara; Tim Holland-Letz; Aydan Yazar; Thomas Fadgyas; Lucie Müller; Andreas Mügge; Alfried Germing
Journal:  Clin Res Cardiol       Date:  2009-08-15       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.